• Mavacamten 2.5mg

Mavacamten 2.5mg

SKU:52153

Mavacamten is used for symptomatic obstructive hypertrophic cardiomyopathy, a heart muscle condition where the thickened heart muscle blocks blood flow and causes symptoms such as breathlessness or chest discomfort.

It is used in adults whose symptoms remain significant and who meet heart-scan monitoring requirements.

Usual dose range: 2.5mg to 15mg once daily, adjusted using echocardiogram results and safety monitoring.


Indications vary by country and change over time; this website contains information for general patient information and should be checked against local prescribing information before clinical use.

Verification Approach: Each indication and usual dose-range sentence was drafted from at least two recognised medicines information sources, usually FDA/DailyMed or an FDA label plus EMA/eMC, MedlinePlus, Mayo Clinic, Cancer Research UK, NCI/ Cancer.gov, or another reputable medicines-information source. Doses are general adult/patient-information ranges and must not be used to prescribe or change treatment.


  • FDA/DailyMed prescribing information and FDA Oncology/Hematology approval notifications.
  • EMA and UK eMC Summary of Product
    Characteristics and patient leaflets where available.
  • NCI Cancer Drug Information/Cancer.gov and Cancer Research UK medicine information where available.
  • MedlinePlus, NHS/NICE, and other national medicines information for non-oncology or immune/respiratory medicines.
  • Peer-reviewed FDA approval summaries or manufacturer regulatory notices for very new, withdrawn, or region-specific
    indications.